University of Pittsburgh
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).
University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.
University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,238 total, page 20 of 25
Retrospective Analysis of Clinical Features in Ventriculoperitoneal Shunt Infectionsin Adults
NCT00524108
Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species
NCT00518661
Fusariosis in Solid-Organ Transplant Recipients
NCT00518778
The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors
NCT01317147
Pneumocystis in Pathogenesis of HIV-associated Emphysema
NCT00869544
Clinical Outcomes and Global Epidemiology -Data Coordinating Center
NCT00524563
Multi-Tracer Pet Quantitation of Insulin Action
NCT00715221
PET Imaging Study of Recovered Anorexics
NCT00603018
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3c
NCT00422851
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3a Part ii
NCT00494364
Evaluation of Group Lifestyle Balance DVD in Primary Care Practice
NCT00480779
Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies
NCT00388427
Chronic Knee Pain Study
NCT00776932
Etiology of Community Acquired Pneumonia
NCT00471757
Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults
NCT00696293
Ventricular Shunt and Drain Infections - Timing of Reimplantation
NCT00470132
Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery
NCT00476021
Parental Involvement and Children's Extra-Familial Contexts
NCT00538252
Effect of Patient-Centered Care (PCC) on Patient Satisfaction at Hospital Discharge
NCT00499161
Determination of Genetic Relatedness of Linezolid-resistant Vancomycin-resistant Enterococci (VRE) Surveillance Cultures
NCT00475891
Effect of Antacids on Gleevec® in Healthy Volunteers
NCT00446316
Risk Factors for Carbapenem-resistant Acinetobacter Baumannii
NCT00462579
Effect of a Proton Pump Inhibitor on Gleevec® in Healthy Volunteers
NCT00446004
Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study
NCT00445913
'Levonorgestrel IUD Insertion After D&E Procedure
NCT00475228
Exercise Training Study for Patients With Cystic Fibrosis
NCT00609050
Quinolone Resistance in Bloodstream Isolates of Escherichia Coli
NCT00449735
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
NCT00436787
Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
NCT00414362
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC
NCT00443885
Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
NCT00414193
Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes
NCT00446355
Prevention of Depression in Spouses of People With Cognitive Impairment
NCT00321971
Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study
NCT00430417
Impact of a Personal Digital Assistant (PDA) - Based Dietary Adherence Intervention on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients
NCT00447408
Low Sodium Diet and Behavioral Intervention for Reversing Arterial Stiffening in Overweight Individuals
NCT00366990
Psychotherapy for Bipolar II Depression, Pilot Study, Phase II
NCT00411463
Study of PEG-Intron for Plexiform Neurofibromas
NCT00396019
Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer
NCT00177853
An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study
NCT00371605
A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients
NCT00336817
Virtual Lifestyle Management: Prevention Through the UPMC Patient Portal
NCT00409786
Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients
NCT00336895
Acute Otitis Media (AOM) Therapy Trial in Young Children
NCT00377260
Behavioral Therapy for Reduction in Smoking Craving
NCT00449293
Efficacy of Sleep Interventions for Posttraumatic Stress Disorder (PTSD)
NCT00393874
Determining Women's Preferences for Medical Abortion Using Willingness to Pay
NCT00472394
Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)
NCT00896142
Media Literacy to Prevent Adolescent Smoking
NCT00398190
Abuse-Focused Cognitive Behavioral Therapy for Children Who Have Been Physically Abused
NCT00494286
What is open in the University of Pittsburgh pipeline
160 recruiting of 1,238 indexed (13% open); 917 completed (74%).
Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Pittsburgh: open-pipeline peers nationwide
Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,238 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Intermountain Health Care · 13% recruiting · 85 trials
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- Temple University · 13% recruiting · 163 trials
Related
What to do with this University of Pittsburgh page
1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.
- 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.